Protagonist Therapeutics
PTGX
PTGX
61 hedge funds and large institutions have $165M invested in Protagonist Therapeutics in 2018 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 20 increasing their positions, 26 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
61
Holders Change
-8
Holders Change %
-11.59%
% of All Funds
1.4%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
8
Increased
20
Reduced
26
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$13.7M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
+$12.3M |
| 3 |
Millennium Management
New York
|
+$8.29M |
| 4 |
Jennison Associates
New York
|
+$3.6M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.85M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
76
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| – | -$4K | -581 | Closed |
|